<!DOCTYPE html>
<html>
<head>
    <title>Topic 1 Analysis: Arterial Endothelial Development and Metabolism</title>
    <style>
        body {
            font-family: Arial, sans-serif;
            line-height: 1.6;
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }
        h1, h2, h3 {
            color: #2c3e50;
        }
        .network-container {
            width: 100%;
            height: 800px;
            border: 1px solid #ddd;
            margin: 20px 0;
        }
        code {
            background-color: #f7f7f7;
            padding: 2px 4px;
            border-radius: 3px;
        }
    </style>
</head>
<body>
    <h1>Topic 1 Analysis: Arterial Endothelial Development and Metabolism</h1>

    <h2>Overview</h2>
    <p>Topic 1 represents a coordinated program of arterial endothelial cell development, angiogenesis, and metabolic regulation. The gene signature suggests active vascular remodeling with strong involvement of Notch and VEGF signaling pathways.</p>

    <h2>Interactive Network</h2>
    <!-- STRING Network iframe -->
    <iframe 
        src="https://string-db.org/cgi/network?identifier=Dll4%0dNotch1%0dHey1%0dFlt1%0dEsm1%0dAngpt2%0dErg%0dEts1%0dWwtr1%0dPrdm1%0dHopx%0dGja1%0dAlcam%0dEng&species=10090&network_flavor=evidence&required_score=400&hide_disconnected_nodes=1"
        style="width:100%; height:800px; border:none;"
        allowfullscreen
        frameborder="0">
    </iframe>

    <h2>Key Pathway Components</h2>

    <h3>1. Arterial Specification Program</h3>
    <h4>Notch Signaling</h4>
    <ul>
        <li><code>Dll4</code> (Delta-like 4): Key arterial fate determinant</li>
        <li><code>Notch1</code>: Arterial specification receptor</li>
        <li><code>Hey1</code>: Notch target transcription factor</li>
        <li><code>Adam10</code>: Notch pathway protease</li>
    </ul>

    <h4>VEGF Pathway</h4>
    <ul>
        <li><code>Flt1</code> (VEGFR1): VEGF receptor</li>
        <li><code>Esm1</code>: VEGF-inducible endothelial marker</li>
        <li><code>Angpt2</code>: Vascular remodeling factor</li>
        <li><code>Flt4</code> (VEGFR3): Lymphatic/venous development</li>
    </ul>

    <!-- Continue with the rest of the content from the markdown -->
    
    <h2>Functional Implications</h2>
    <ol>
        <li><strong>Vascular Development</strong>
            <ul>
                <li>Strong arterial specification program</li>
                <li>Active angiogenic signaling</li>
                <li>ECM remodeling capacity</li>
            </ul>
        </li>
        <li><strong>Metabolic Adaptation</strong>
            <ul>
                <li>Enhanced nutrient transport</li>
                <li>Active metabolic regulation</li>
                <li>Energy metabolism flexibility</li>
            </ul>
        </li>
    </ol>

    <h2>Statistical Summary</h2>
    <ul>
        <li>Total genes analyzed: 300</li>
        <li>Key pathway components: ~40% of top genes</li>
        <li>Major functional categories:
            <ul>
                <li>Arterial development: 25%</li>
                <li>Metabolism: 20%</li>
                <li>Cell signaling: 30%</li>
                <li>ECM/Adhesion: 15%</li>
                <li>Others: 10%</li>
            </ul>
        </li>
    </ul>
</body>
</html> 